Navigation Links
Questcor Provides Donation In Support Of Children's Hospital & Research Center Oakland
Date:12/17/2013

HAYWARD, Calif., Dec. 17, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ:   QCOR) today announced that it has made a $25,000 donation to the Children's Hospital & Research Center Oakland in support of the Early Intervention Services program.

Children's Hospital & Research Center Oakland is a premier, not-for-profit medical center for children in Northern California, and is the only hospital in the East Bay that is 100% devoted to pediatrics. Their Early Intervention Services program supports the well-being, development and caregiving relationships of infants and young children (up to age 6) who have developmental, social-emotional and medically related vulnerabilities or disabilities.

"Questcor is committed to giving back to our local community," said Steve Cartt, Chief Operating Officer for Questcor. "We feel privileged to be able to support such a worthy institution, particularly one that is funded solely by grants and charitable contributions.  Our hope is that these funds will help improve the quality of life for some Bay Area children who are in need."

In addition to the financial contribution, Mr. Cartt noted that Questcor employees in Hayward created get well cards for children being treated at the hospital.  These cards are distributed to children on their lunch trays.  "In addition to the donation, we wanted to find a way to more personally connect with the children and their families, especially during the holiday season," Mr. Cartt said.  "This seemed to be a great way to do it."

Susan Greenwald, Director of Early Intervention Services, shared, "We're grateful for Questcor's generous donation and look forward to putting the money to good use serving children and families.  We also appreciate the time and effort Questcor employees gave to produce beautiful get-well cards.  I know they will help lift the spirits of our courageous young patients."

About Children's Hospital & Research Center
Children's Hospital & Research Center Oakland is a national leader in many pediatric specialties including hematology/oncology, neonatology, cardiology, orthopaedics, sports medicine, and neurosurgery. The hospital is one of only two solely designated California Level 1 pediatric trauma centers in the region, and has one of largest pediatric intensive care units in Northern California.  Children's is also a leading teaching hospital with an outstanding pediatric residency program and a number of unique pediatric subspecialty fellowship programs.

Children's research arm, Children's Hospital Oakland Research Institute is internationally known for its basic and clinical research.  CHORI is at the forefront of translating research into interventions for treating and preventing human diseases.  

Each year, more than 75,000 children from the San Francisco Bay Area and the country receive care.  No child is turned away because of a family's inability to pay.  For more information, please visit www.childrenshospitaloakland.org.

About Questcor Pharmaceuticals
Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Questcor's specific areas of focus are in the fields of neurology, nephrology and rheumatology, and the company is currently supporting research efforts in a variety of conditions having significant unmet medical need. For more information about Questcor, please visit www.questcor.com


'/>"/>
SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Partnerships, Appointments, New Products, Public Offerings, and Agreements - Research Report on Questcor Pharmaceuticals, Hologic, IDEXX, Endologix, and Healthways
2. Questcor Announces Quarterly Cash Dividend and Provides Update on Share Repurchase Program
3. Questcor Pharmaceuticals to Present at the Oppenheimer Annual Healthcare Conference
4. Biologics License Applications, Event Participations, and Stock Movements - Research Report on Baxter, WellPoint, Questcor Pharmaceuticals, CareFusion, and Hologic
5. Product Reviews, Recognitions, FDA Responses, and New Leadership Appointments - Research Report on Gilead, WellPoint, Questcor, Forest Laboratories, and Envision Healthcare
6. Questcor Honored as an "Everyday Hero" by NephCure Foundation
7. Questcor Adds G. Kelly Martin to Board of Directors
8. Questcor Pharmaceuticals to Present at the 2013 Credit Suisse Annual Healthcare Conference
9. Questcor Reports Third Quarter Financial Results
10. Questcor To Commence Phase 2 Study of Acthar for Acute Respiratory Distress Syndrome
11. Questcor Pharmaceuticals to Participate in Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical ... patients in Nashville , Tennesse have ... Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. The ... provide long-term reflux control by restoring normal function to ... 65 million people in the United States ...
(Date:4/19/2017)... BOSTON , April 19, 2017  New research provides ... with advanced Parkinson,s, according to a study released today that ... 69th Annual Meeting in Boston , ... comes to the treatment of Parkinson,s disease, the oral drug ... of life and longevity. But as the disease progresses, the ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global ... and Gynecology markets with innovative and proprietary products, will ... 31, 2017 after the market close on Tuesday, May ... a conference call and webcast to discuss its financial ... at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
Breaking Medicine Technology:
(Date:4/24/2017)... Seattle, Washington (PRWEB) , ... April 24, 2017 , ... ... T-Fal OptiGrill, Oxiclean, Space Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill ... than perhaps any other marketer in the last 25 years. , Now, due to ...
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class designers ... to bring their novel lifesaving device for the everyday use of parents worldwide. ... specially designed to read a child’s vital signs, and detect unusual symptoms or ...
(Date:4/24/2017)... ... April 24, 2017 , ... According to ... deaths now claim the lives of 62 Americans each day.(1) Yet since 2011, ... manufacturers, distributors, pharmacies and prescribers by more than half.(2) Novus Medical Detox ...
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, ... HIV because it is not known to have significant interactions with antiretroviral therapy ... both lower cholesterol levels and dampen inflammation in the bloodstream. , While lowering ...
(Date:4/24/2017)... FOREST KNOLLS, Calif. (PRWEB) , ... April 24, 2017 , ... ... and health topics, but she has not found any of them to be very ... weekly actions to slowly and easily make changes in their health. It prompted her ...
Breaking Medicine News(10 mins):